Clinical study of Buyang Huanwu Decoction Combined with anticoagulant early intervention on the prevention of post thrombosis syndrome of lower extremity deep vein

Wangjing Hospital of CACMS0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Conform to the above-mentioned diagnosis of deep vein thrombosis of lower extremities (medical history + ultrasound + laboratory examination); (2) aged between 30 and 75 years old; (3) not receiving systemic anticoagulation; (4) no serious cardiac, Patients with primary diseases or mental diseases such as brain, liver, kidney, malignant tumor and hematopoietic system; (5) Patients are suitable and willing to accept clinical trials and sign informed consent.

•(1) Under 30 years old or older than 75 years old; (2) Those with recurrent DVT, or a definite diagnosis of PTS; (3) Those who have received or plan to receive systemic intravenous thrombolysis, catheter-based thrombolysis or incision for thrombectomy, (4) Patients with absolute contraindications to anticoagulation (subarachnoid and intracerebral hemorrhage, severe active hemorrhage, malignant hypertension, recent brain, eye, and spine surgery) or relative contraindications (active gastrointestinal bleeding, hemorrhagic constitution, recent stroke, recent major surgery); (5) pregnant and lactating women; (6) complicated with severe cardiovascular, renal, hepatic, peptic ulcer, hematopoietic system (7) Those who suffer from mental illness or other reasons for not cooperating; (8) Those who are allergic or known to be allergic to the drugs and their components used in this test.

发起方

Wangjing Hospital of CACMS